Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy: Annals of Hematology

M. Tiribelli, E. Abruzzese, I. Capodanno, F. Sorà, E. Trabacchi, A. Iurlo, L. Luciano, G. Binotto, M. Bonifacio, M. Annunziata, M. Crugnola, R. Fanin

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2609-2611
Number of pages3
JournalAnn. Hematol.
Volume98
Issue number11
DOIs
Publication statusPublished - Nov 1 2019

Keywords

  • BCR ABL protein
  • bosutinib
  • creatinine
  • dasatinib
  • imatinib
  • nilotinib
  • triacylglycerol lipase
  • aniline derivative
  • nitrile
  • quinoline derivative
  • adult
  • aged
  • chronic myeloid leukemia
  • clinical article
  • cohort analysis
  • comorbidity
  • creatinine blood level
  • cytogenetics
  • diarrhea
  • disease classification
  • disease severity
  • drug efficacy
  • drug response
  • drug safety
  • drug withdrawal
  • female
  • follow up
  • gene mutation
  • headache
  • human
  • Italy
  • Letter
  • male
  • middle aged
  • nausea
  • patient referral
  • pleura effusion
  • priority journal
  • retrospective study
  • skin toxicity
  • treatment duration
  • triacylglycerol lipase blood level
  • clinical trial
  • epidemiology
  • malignant pleura effusion
  • mortality
  • multicenter study
  • very elderly
  • Aged
  • Aged, 80 and over
  • Aniline Compounds
  • Dasatinib
  • Female
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Male
  • Middle Aged
  • Nitriles
  • Pleural Effusion, Malignant
  • Quinolines
  • Retrospective Studies

Cite this